BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26501538)

  • 1. Optimizing Mammography Screening Intervals.
    Yi M; Hunt KK
    JAMA; 2015 Oct; 314(15):1635-6. PubMed ID: 26501538
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the Effectiveness of Mammography.
    Chen WY
    JAMA Oncol; 2015 Nov; 1(8):1037-8. PubMed ID: 26501739
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated 2D and 3D mammography.
    Sumkin JH
    Lancet Oncol; 2013 Jul; 14(8):e292-3. PubMed ID: 23816295
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening mammography after autologous breast reconstruction is not beneficial.
    Barton MK
    CA Cancer J Clin; 2015; 65(1):3-4. PubMed ID: 25533748
    [No Abstract]   [Full Text] [Related]  

  • 5. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
    Barratt A
    BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
    Lousdal ML; Kristiansen IS; Møller B; Støvring H
    Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammorgraphy reporting at Tygerberg hospital, Cape Town, South Africa.
    Pitcher R; Lotz J; Ackermann C; Bagadia A; Davis R; du Plessis AM; Griffith-Richards S; Hattingh R; Wagener G
    S Afr Med J; 2014 Jul; 104(7):456. PubMed ID: 25298984
    [No Abstract]   [Full Text] [Related]  

  • 13. Case quiz. Intracystic papillary carcinoma of the breast.
    Muttarak M; Chaiwun B; Trakultivakorn H
    Australas Radiol; 2002 Mar; 46(1):129-31. PubMed ID: 11966605
    [No Abstract]   [Full Text] [Related]  

  • 14. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
    J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiodiagnosis of minimal breast cancer].
    Semiglazov VV; Krzhivitskiĭ PI
    Vopr Onkol; 2001; 47(1):99-102. PubMed ID: 11317549
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
    Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of digital screening mammography among older women in the United States.
    Henderson LM; O'Meara ES; Braithwaite D; Onega T;
    Cancer; 2015 May; 121(9):1379-86. PubMed ID: 25537958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-aided detection in mammography: downstream effect on diagnostic testing, ductal carcinoma in situ treatment, and costs.
    Fenton JJ; Lee CI; Xing G; Baldwin LM; Elmore JG
    JAMA Intern Med; 2014 Dec; 174(12):2032-4. PubMed ID: 25347134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.